Your browser doesn't support javascript.
loading
Innovative vaccine approaches-a Keystone Symposia report.
Cable, Jennifer; Rappuoli, Rino; Klemm, Elizabeth J; Kang, Gagandeep; Mutreja, Ankur; Wright, Gavin J; Pizza, Mariagrazia; Castro, Sowmya Ajay; Hoffmann, Joseph P; Alter, Galit; Carfi, Andrea; Pollard, Andrew J; Krammer, Florian; Gupta, Ravindra K; Wagner, Caroline E; Machado, Viviane; Modjarrad, Kayvon; Corey, Lawrence; B Gilbert, Peter; Dougan, Gordon; Lurie, Nicole; Bjorkman, Pamela J; Chiu, Christopher; Nemes, Elisa; Gordon, Stephen B; Steer, Andrew C; Rudel, Thomas; Blish, Catherine A; Sandberg, John Tyler; Brennan, Kiva; Klugman, Keith P; Stuart, Lynda M; Madhi, Shabir A; Karp, Christopher L.
Afiliação
  • Cable J; PhD Science Writer, New York, New York.
  • Rappuoli R; GSK, Siena, Italy.
  • Klemm EJ; Wellcome Trust, Bloomsbury, London, UK.
  • Kang G; Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Mutreja A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK.
  • Wright GJ; Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Hinxton, UK.
  • Pizza M; Department of Biology, Hull York Medical School, and York Biomedical Research Institute, University of York, York, UK.
  • Castro SA; GSK, Siena, Italy.
  • Hoffmann JP; Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, UK.
  • Alter G; Departments of Pediatrics and Medicine, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana.
  • Carfi A; Ragon Institute of MGH, MIT and Harvard, Harvard Medical School, Cambridge, Massachusetts.
  • Pollard AJ; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Krammer F; Moderna Inc., Cambridge, Massachusetts.
  • Gupta RK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
  • Wagner CE; The Tisch Cancer Institute and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Machado V; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK.
  • Modjarrad K; Africa Health Research Institute, Durban, South Africa.
  • Corey L; Department of Bioengineering, McGill University, Montreal, Quebec, Canada.
  • B Gilbert P; Measles and Respiratory Viruses Laboratory, WHO/NIC, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
  • Dougan G; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland.
  • Lurie N; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington.
  • Bjorkman PJ; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Chiu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Nemes E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Gordon SB; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK.
  • Steer AC; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
  • Rudel T; Harvard Medical School, Boston, Massachusetts.
  • Blish CA; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.
  • Sandberg JT; Department of Infectious Disease, Imperial College London, London, UK.
  • Brennan K; Division of Immunology, Department of Pathology, South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Klugman KP; Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
  • Stuart LM; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Madhi SA; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Karp CL; Department of General Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia.
Ann N Y Acad Sci ; 1511(1): 59-86, 2022 05.
Article em En | MEDLINE | ID: mdl-35029310

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022